Giuliano Ramadori

Prof. Dr. Giuliano Ramadori

Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2001 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori
TAThomas Armbrust
Thomas Armbrust
Cytokines comprise a group of small proteins released from cells in order to influence the function of other cells. By binding to highly specific cell-surface receptors, they trigger a vast array of intracellular signalling cascades. Cytokines have been described as interleukins, growth factors, interferons and chemokines. Unlike hormones, which act in a similar way, cytokines are produced by many different types of cell and act on many other types. Most of them are produced only after certain stimuli. The most intense field of cytokine activity is without doubt host defence. The liver resembles a central organ of cytokine activity due to the fact that it hosts hepatocytes, which are highly susceptible to the activity of cytokines in a variety of physiological and pathophysiological processes. Moreover, the non-parenchymal cells of the liver, in particular Kupffer cells (KCs), the resident tissue macrophages of the liver, are able to synthesize a variety of cytokines that may act systemically on any other organ of the body, or in a paracrine manner on hepatocytes and other non-parenchymal liver cells. A classic example of how cytokines act can be observed during the acute phase reaction discussed in this article. The role of cytokines in liver development, acute liver injury, liver regeneration, liver fibrosis and liver metastasis is also discussed.

1 July 1999 in Hepatology
Verified
Journal Article
Open access
PDF file
BSBernhard Saile
Bernhard Saile
NMNina Matthes
Nina Matthes
TKThomas Knittel
Thomas Knittel
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori
Transforming growth factor β (TGF-β) as well as tumor necrosis factor α (TNF-α) gene expression are up-regulated in chronically inflamed liver. These cytokines were investigated for their influence on apoptosis and proliferation of activated hepatic stellate cells (HSCs). Spontaneous apoptosis in activated HSC was significantly down-regulated by 53% ± 8% (P < .01) under the influence of TGF-β and by 28% ± 2% (P < .05) under the influence of TNF-α. TGF-β and TNF-α significantly reduced expression of CD95L in activated HSCs, whereas CD95 expression remained unchanged. Furthermore, HSC apoptosis induced by CD95-agonistic antibodies was reduced from 96% ± 2% to 51 ± 7% (P < .01) by TGF-β, and from 96% ± 2% to 58 ± 2% (P < .01) by TNF-α, suggesting that intracellular antiapoptotic mechanisms may also be activated by both cytokines. During activation, HSC cultures showed a reduced portion of cells in the G0/G1phase and a strong increment of G2-phase cells. This increment was significantly inhibited (G1 arrest) by administration of TGF-β and/or TNF-α to activated cells. In liver sections of chronically damaged rat liver (CCl4 model), using desmin and CD95L as markers for activated HSC, most of these cells did not show apoptotic signs (TUNEL-negative). Taken together, these findings indicate that TGF-β and/or TNF-α both inhibit proliferation and also apoptosis in activated HSC in vitro. Both processes seem to be linked to each other, and their inhibition could represent the mechanism responsible for prolonged survival of activated HSC in chronic liver damage in vivo.

1 January 1999 in The American Journal of Pathology
Verified
Journal Article
Closed access
TKThomas Knittel
Thomas Knittel
CDChristina Dinter
Christina Dinter
DKDominik Kobold
Dominik Kobold
KNKatrin Neubauer
Katrin Neubauer
MMMirko Mehde
Mirko Mehde
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori

1 August 2002 in Liver International
Verified
Journal Article
Closed access
PDF file
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori
BSB. Saile
B. Saile

1 January 2001 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
KNKatrin Neubauer
Katrin Neubauer
BSBernhard Saile
Bernhard Saile
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori
Liver fibrosis represents the uniform response of liver to toxic, infectious or metabolic agents. The process leading to liver fibrosis resembles the process of wound healing, including the three phases following tissue injury: inflammation, synthesis of collagenous and noncollagenous extracellular matrix components, and tissue remodelling (scar formation). While a single liver tissue injury can be followed by an almost complete restitution ad integrum, the persistence of the original damaging noxa results in tissue damage. During the establishment of liver fibrosis, the basement membrane components collagen type IV, entactin and laminin increase and form a basement membrane-like structure within the space of Disse. The number of endothelial fenestrae of the sinusoids decreases. These changes of the sinusoids are called 'capillarization' because the altered structure of the sinusoids resembles that of capillaries. At the cellular level, origin of liver fibrogenesis is initiated by the damage of hepatocytes, resulting in the recruitment of inflammatory cells and platelets, and activation of Kupffer cells, with subsequent release of cytokines and growth factors. The hepatic stellate cells seem to be the primary target cells for these inflammatory stimuli, because during fibrogenesis, they undergo an activation process to a myofibroblast-like cell, which represents the major matrix-producing cell. Based on this pathophysiological mechanism, therapeutic methods are developed to inhibit matrix synthesis or stimulate matrix degradation. A number of substances are currently being tested that either neutralize fibrogenic stimuli and prevent the activation of hepatic stellate cells, or directly modulate the matrix metabolism. However, until now, the elimination of the hepatotoxins has been the sole therapeutic concept available for the treatment of liver fibrogenesis in humans.

16 February 2011 in Histochemistry and Cell Biology
Verified
Journal Article
Open access
PDF file
AAAhmad Amanzada
Ahmad Amanzada
IMIhtzaz Malik
Ihtzaz Malik
MNMartin Nischwitz
Martin Nischwitz
SSSadaf Sultan
Sadaf Sultan
NNNaila Naz
Naila Naz
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori
Myeloperoxidase (MPO) is involved in acute and chronic inflammatory diseases. The source of MPO in acute liver diseases is still a matter of debate. Therefore, we analysed MPO-gene expression on sections from normal and acutely damaged [carbon tetrachloride-(CCl4) or whole liver γ-Irradiation] rat liver by immunohistochemistry, real time PCR and Western blot analysis of total RNA and protein. Also total RNA and protein from isolated Kupffer cells, hepatic stellate cells, Hepatocytes, endothelial cells and neutrophil granulocytes (NG) was analysed by real time PCR and Western blot, respectively. Sections of acutely injured human liver were prepared for MPO and CD68 immunofluorescence double staining. In normal rat liver MPO was detected immunohistochemically and by immunofluorescence double staining only in single NG. No MPO was detected in isolated parenchymal and non-parenchymal cell populations of the normal rat liver. In acutely damaged rat liver mRNA of MPO increased 2.8-fold at 24 h after administration of CCl4 and 3.3-fold at 3 h after γ-Irradiation and MPO was detected by immunofluorescence double staining only in elastase (NE) positive NGs but not in macrophages (ED1 or CD68 positive cells). Our results demonstrate that, increased expression of MPO in damaged rat and human liver is due to recruited elastase positive NGs.